We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
The new medicine has shown 15 times more anti-tumour activity than docetaxel, the most commonly used treatment for prostate cancer that is resistant to hormonotherapy.
